Page last updated: 2024-10-29

ketanserin and Thrombocytopathy

ketanserin has been researched along with Thrombocytopathy in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Egermayer, P1
Town, GI1
Peacock, AJ1
Herve, P1
Drouet, L1
Dosquet, C1
Launay, JM1
Rain, B1
Simonneau, G1
Caen, J1
Duroux, P1

Reviews

1 review available for ketanserin and Thrombocytopathy

ArticleYear
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.
    Thorax, 1999, Volume: 54, Issue:2

    Topics: Blood Platelet Disorders; Collagen Diseases; Humans; Hypertension, Portal; Hypertension, Pulmonary;

1999

Other Studies

1 other study available for ketanserin and Thrombocytopathy

ArticleYear
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.
    The American journal of medicine, 1990, Volume: 89, Issue:1

    Topics: Blood Platelet Disorders; Blood Platelets; Blood Pressure; Humans; Hypertension, Pulmonary; Ketanser

1990